Uncategorized Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Receives Average Rating of “Buy” from Brokerages otakuyassine3@gmail.com Feb 14, 2025 Shares of Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Get Free Report) have received an average recommendation...